Skip to main content
Caplight Logo









SelekTx

SelekTx

Private
DublinHealthcare & Life Scienceshttps://selektx.com/

Last Round

Series A

Jan 16, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SelekTx is a biotechnology company that develops a platform for engineering precision biologics to target hard-to-drug disease proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

biologic drug discoveryGPCR targetingprecision medicinedrug discovery platformprotein scaffoldspreclinical drug developmentbiotech licensingdrug discovery AIin silico drug designG protein-coupled receptorsGPCRcomputational biologybiologicspharma partneringAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SelekTx Comparables

Compare SelekTx with similar companies based on industry and business-model similarity.

SelekTx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Skape Bio
84%
Orion Biotechnology
81%
Orbit Discovery
77%

SelekTx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 16, 2026
GrantDec 2, 2024
GrantJun 23, 2024

SelekTx Investors

Notable investors and investment history

SelekTx investors
InvestorRounds
Novo Nordisk FoundationGrant
Enterprise IrelandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 16, 2026

    $12M round completed.

  • Jun 23, 2024

    Received funding from Enterprise Ireland.

SelekTx Filings

Explore SEC and related filing metadata, where available.

SelekTx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SelekTx's valuation, stock price, and market status.

Is SelekTx a public or private company?

SelekTx is a private company.

What is the current stock price of SelekTx?

SelekTx is a private company with no public stock price. No recent secondary market data is available.

How much is SelekTx worth (valuation)?

Valuation information for SelekTx is not publicly available.

Can I buy SelekTx stock?

SelekTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SelekTx's last funding round?

SelekTx's most recent funding round was Series A on January 16, 2026.

Who are the main investors in SelekTx?

Key investors in SelekTx include Novo Nordisk Foundation, Enterprise Ireland.

Will SelekTx IPO soon?

No public IPO plans have been announced for SelekTx.

How can I track SelekTx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SelekTx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDublin
Employee Range3
Year Founded2024
Last FundingJan 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?